Iridex Corp

Iridex Corp, a Mountain View, California-based manufacturer of laser-based medical systems and ophthalmic equipment, operates as a prime contractor selling specialized medical devices to the federal government through open-market delivery orders and purchase orders with no set-aside designations. The company competes entirely in full-and-open procurements across a diverse portfolio of 742 prime awards spanning 34 customer agencies, with particular concentration among Defense Department and Veterans Affairs healthcare operations.

Iridex's federal capability footprint centers on ophthalmic and otolaryngology laser systems, endoprobes, laser probes, protective equipment, and related accessories, along with laser repair and maintenance services. Representative recent work includes a $117,630 532-nanometer diode laser awarded by DLA Medical Supply Chain in September 2025, a $94,084 577-nanometer diode laser with multipass capability awarded in the same month, and a $77,125 IQ577 system delivered to DLA in May 2022. The company also holds a GSA Schedule contract (Medical Equipment and Supplies, FSS-65-II-A) through which it has supplied glaucoma and laser systems to Veterans Health Administration facilities, including a $25,300 Cyclo G6 laser system to VISN 21 and a $21,200 glaucoma laser system to VISN 6.

The Defense Logistics Agency Troop Support Medical dominates Iridex's customer base by both volume and dollars, representing 241 awards (32% of the total portfolio) valued at $11.8 million combined potential value — roughly 52% of the company's total federal addressable market. The Department of Veterans Affairs Veterans Health Administration operates as the second-largest customer by potential value, with five awards to VISN 12 carrying $3.6 million combined value; additional VA VISN operations (6, 1, 17, and 21) collectively anchor another $800 thousand across maintenance contracts and equipment purchases. Department of the Army Medical Command and the Department of the Navy Bureau of Medicine and Surgery round out the top five, accounting for $1.4 million and $744 thousand respectively. This concentration reflects Iridex's primary market positioning as a supplier to military and veterans' healthcare logistics and clinical operations.

Iridex's parent vehicle footprint is anchored by its single-award indefinite-delivery contract (SPE2DH22D0011) with DLA Troop Support Medical, valued at $5.16 million through March 2027 and awarded in March 2022. This IDIQ has generated 98 task orders valued at $889 thousand. Beyond the DLA IDIQ, the company places orders through two GSA Federal Supply Schedules — Schedule V797P4329A (162 task orders, $3.3 million) and Schedule V797P3815J (21 task orders) — and participates in the DLA Medical Capital Equipment Program (136 task orders, $858 thousand) and the Medical Equipment and Supplies vehicle (65 task orders, $2.4 million). The multi-vehicle posture enables Iridex to reach military treatment facilities, VA medical centers, and other federal healthcare customers across supply chains managed by DLA, GSA, and agency-specific purchasing.

Activity trajectory shows moderation after a 2022 peak of 38 awards, declining to 11 awards year-to-date in 2026 (as of July 8, 2026). This decline reflects both the maturation of the 2022-era IDIQ vehicle and potential portfolio concentration risk within the DLA supply chain. Recompete visibility is minimal in the provided source; the SPE2DH IDIQ does not expire until March 2027, providing runway for continued task-order activity into 2027.

Iridex's award portfolio is concentrated in three NAICS categories: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (240 awards), Surgical Appliance and Supplies Manufacturing (164 awards), and Electromedical and Electrotherapeutic Apparatus Manufacturing (114 awards). By PSC code, Medical and Surgical Instruments, Equipment, and Supplies (PSC 6515) account for 350 awards, Hospital Furniture and Equipment (PSC 7110) for 222, and Ophthalmic Instruments and Equipment (PSC 6640) for 66. This categorization framing reflects Iridex's mixed posture as both a direct equipment manufacturer and a distributor of commercial medical goods through federal supply channels.